more generic ARBs in 2012
You'll see more generic ARBs in 2012...irbesartan (Avapro) in March...valsartan (Diovan) in Sept...and candesartan (Atacand) in Dec.
But don't let this lure you into using them first-line instead of ACE inhibitors. ACEIs still have more evidence for improving outcomes.
When you do use an ARB, expect formularies to force switching from brand to generic.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote